arsenic trioxide has been researched along with Hepatoblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, Y; Guo, BB; Jiang, HY; Li, S; Liu, LY; Wang, KK; Wu, CJ; Zhang, CM; Zhang, F; Zhang, Y | 1 |
| Wang, ZH; Yu, D; Zhu, LY | 1 |
2 other study(ies) available for arsenic trioxide and Hepatoblastoma
| Article | Year |
|---|---|
Low dosage of arsenic trioxide inhibits vasculogenic mimicry in hepatoblastoma without cell apoptosis.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Survival; Dose-Response Relationship, Drug; Hep G2 Cells; Hepatoblastoma; Humans; Liver Neoplasms; Male; Mice, Nude; Neovascularization, Pathologic; Oxides; Xenograft Model Antitumor Assays | 2018 |
[Mechanism of arsenic trioxide-induced apoptosis in hepatic blastoma cells HepG2].
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Hep G2 Cells; Hepatoblastoma; Humans; Liver Neoplasms; Nuclear Proteins; Oxides; Promyelocytic Leukemia Protein; Transcription Factors; Tumor Suppressor Proteins | 2003 |